User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse




Journal Article

Heritable sclerosing bone disorders: presentation and new molecular mechanisms.


Kornak,  U.
Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society;

There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available

de Vernejoul, M. C., & Kornak, U. (2010). Heritable sclerosing bone disorders: presentation and new molecular mechanisms. Annals of the New York Academy of Sciences, 1192, 269-277. doi:10.1111/j.1749-6632.2009.05244.x.

Cite as: http://hdl.handle.net/11858/00-001M-0000-0010-7B68-E
Sclerosing bone disorders can be subdivided according to their clinical presentation, the primarily affected cell type, and the cellular pathways. Osteoclast-rich osteopetrosis and related disorders have been related in most cases to mutations in genes required for osteoclast function. More recently, osteoclast-poor forms of osteopetrosis have been described as being connected to factors that govern osteoclast differentiation. However, increased bone formation can also cause osteosclerosis. Camurati-Engelman disease and osteopoikilosis are both related transforming growth factor-beta signaling. Rare recessive or dominant sclerosing disorders, such as endosteal hyperostosis, sclerosteosis, van Buchem disease, high bone-mass syndrome, and osteopathia striata, are caused by mutations in genes involved in the Wnt pathway, which regulates osteoblast differentiation. Finally, a third entity, including Ghosal syndrome and pachydermoperiostosis, is related to mutations in genes of the eicosanoid pathway. Clinical aspects and the consequences for our understanding of bone biology are discussed.